Palliative radiotherapy: No added benefit for individuals with advanced oesophageal cancer
31 May 2021
byAudrey Abella
Apart from reducing bleeding risk in individuals with advanced oesophageal cancer (ESCA) who had self-expanding metal stent (SEMS) insertion to improve dysphagia, concurrent palliative radiotherapy (RT) does not reduce recurrent dysphagia nor does it improve overall survival (OS), findings from the phase III ROCS* study have shown.